(2Z)-N-[4-(1H-1,3-Benzodiazol-2-yl)phenyl]-8-methoxy-2-[(2-methylphenyl)imino]-2H-chromene-3-carboxamide

Catalog No. :
ACTYVR675
CAS No. :
478343-11-2
Molecular Formula :
C31H24N4O3
Molecular Weight :
500.56

IUPAC Name:(Z)-N-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-8-methoxy-2-(o-tolylimino)-2H-chromene-3-carboxamide

(2Z)-N-[4-(1H-1,3-Benzodiazol-2-yl)phenyl]-8-methoxy-2-[(2-methylphenyl)imino]-2H-chromene-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$313.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2Z)-N-[4-(1H-1,3-Benzodiazol-2-yl)phenyl]-8-methoxy-2-[(2-methylphenyl)imino]-2H-chromene-3-carboxamide
IUPAC Name(Z)-N-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-8-methoxy-2-(o-tolylimino)-2H-chromene-3-carboxamide
MDL No.MFCD03047797
Molecular FormulaC31H24N4O3
Molecular Weight500.56
SMILESCOC1=CC=CC2=C1O/C(=N\C1=CC=CC=C1C)C(C(=O)NC1=CC=C(C3=NC4=CC=CC=C4N3)C=C1)=C2
InChI KeyQTCZFWNOPWWANM-LLZINOMRSA-N
Synonym(2Z)-N-[4-(1H-1,3-benzodiazol-2-yl)phenyl]-8-methoxy-2-[(2-methylphenyl)imino]-2H-chromene-3-carboxamide;2H-1-Benzopyran-3-carboxamide, N-[4-(1H-benzimidazol-2-yl)phenyl]-8-methoxy-2-[(2-methylphenyl)imino]-
CAS No.478343-11-2

Synthetic Route by SureRoute

1. ACTYVR675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTNB968 route compound structure diagram
    ACJTNB9682963-77-1 In Stock
  4. Then
  5. ACTYVR675 route product structure diagram
    ACTYVR675478343-11-2
Inquiry

2. ACTYVR675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTNB968 route compound structure diagram
    ACJTNB9682963-77-1 In Stock
  4. Then
  5. ACTYVR675 route product structure diagram
    ACTYVR675478343-11-2
Inquiry

Comments (0)